Liontrust Investment Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,160
Closed -$7.64M 205
2023
Q2
$7.64M Sell
25,160
-7,100
-22% -$1.97M 0.11% 110
2023
Q1
$8.51M Hold
32,260
0.12% 110
2022
Q4
$7.74M Sell
32,260
-2,600
-7% -$582K 0.14% 73
2022
Q3
$6.41M Hold
34,860
0.1% 111
2022
Q2
$5.86M Hold
34,860
0.08% 135
2022
Q1
$8.74M Hold
34,860
0.11% 85
2021
Q4
$8.96M Hold
34,860
0.11% 100
2021
Q3
$8.46M Buy
+34,860
New +$8.52M 0.12% 97
2020
Q4
$5.98M Buy
+36,360
New +$5.32M 0.12% 101

Other funds holding HCA

Liontrust Investment Partners's HCA Position: Q3 2023 in Review

Liontrust Investment Partners sold out of HCA Healthcare (HCA) in Q3 2023, closing a stake of 25,160 shares — an estimated $7.64M sold.

Liontrust Investment Partners first reported a position in HCA in Q4 2020 and held it in 9 quarters. The position peaked at $8.96M in Q4 2021. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

  • Liontrust Investment Partners reported no remaining HCA Healthcare position as of Q3 2023 after selling out during the quarter.
  • Liontrust Investment Partners sold 25,160 HCA Healthcare shares in Q3 2023, an estimated $7.64M.
  • Liontrust Investment Partners first reported a position in HCA Healthcare in Q4 2020 and held it in 9 quarters.
  • Liontrust Investment Partners's HCA Healthcare position peaked at $8.96M in Q4 2021.
  • 1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Liontrust Investment Partners's 13F filing for Q3 2023, filed 9 Nov 2023.